Optimal duration of adjuvant bisphosphonate treatment for high-risk early breast cancer: Results from a SUCCESS trial

Thorac Cancer. 2022 Feb;13(3):519-520. doi: 10.1111/1759-7714.14257. Epub 2022 Jan 2.
No abstract available

Keywords: SUCCESS A trial; adjuvant bisphosphonate treatment; breast cancer; treatment duration.

Publication types

  • Letter
  • Comment

MeSH terms

  • Breast
  • Breast Neoplasms* / drug therapy
  • Chemotherapy, Adjuvant
  • Diphosphonates* / therapeutic use
  • Female
  • Humans

Substances

  • Diphosphonates